This article was originally published by the American Journal of Managed Care.

Multicancer early detection tests are revolutionizing cancer screening by using liquid biopsies to screen for multiple cancers from a single blood sample, enhancing patient outcomes by identifying cancers earlier.

Detection and treatment of cancer in earlier stages remain a key strategy for improving outcomes; however, typical screening methods are commonly ineffective or nonexistent for some types of cancer. The long-desired "holy grail" of cancer detection would be a single test that could seamlessly detect cancer during a routine health check-up. This aspiration is closer to a reality with multicancer early detection (MCED) assays, which offer the potential to revolutionize screening by detecting multiple

See Full Page